Zevia PBC (NYSE:ZVIA) Given Average Recommendation of "Hold" by Brokerages

Key Points

• Analysts have an average recommendation of "Hold" on Zevia across six firms (1 sell, 2 hold, 3 buy), with a consensus 12‑month price target of about $4.43.
• There has been notable insider selling: CFO Girish Satya sold 41,662 shares at $1.18 and major shareholder De Depot Et Placement D. Caisse sold 3.5 million shares at $2.00, leaving insiders owning 11.11% of the company.
• Zevia trades around $1.29$96.5 million, a 52‑week range of $1.11–$3.66, and remains unprofitable (negative EPS and a -6.15% net margin) with analysts forecasting about -$0.06 EPS for the year.

Shares of Zevia PBC (NYSE:ZVIA - Get Free Report) have been assigned an average recommendation of "Hold" from the six research firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $4.4250.

Several research firms recently weighed in on ZVIA. Telsey Advisory Group cut their target price on shares of Zevia PBC from $6.00 to $5.00 and set an "outperform" rating for the company in a research note on Thursday, February 26th. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Zevia PBC in a research note on Monday, April 20th. Finally, Craig Hallum began coverage on shares of Zevia PBC in a research note on Thursday, January 15th. They set a "buy" rating and a $4.00 target price for the company.

Insider Buying and Selling at Zevia PBC

In other Zevia PBC news, CFO Girish Satya sold 41,662 shares of Zevia PBC stock in a transaction on Wednesday, March 25th. The shares were sold at an average price of $1.18, for a total value of $49,161.16. Following the completion of the transaction, the chief financial officer directly owned 327,909 shares of the company's stock, valued at $386,932.62. This trade represents a 11.27% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, major shareholder De Depot Et Placement D. Caisse sold 3,500,000 shares of Zevia PBC stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $2.00, for a total transaction of $7,000,000.00. Following the completion of the transaction, the insider directly owned 13,550,428 shares of the company's stock, valued at $27,100,856. The trade was a 20.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 11.11% of the company's stock.

Hedge Funds Weigh In On Zevia PBC

Institutional investors and hedge funds have recently made changes to their positions in the business. Divisadero Street Capital Management LP grew its stake in shares of Zevia PBC by 90.6% in the 3rd quarter. Divisadero Street Capital Management LP now owns 6,159,362 shares of the company's stock worth $16,753,000 after buying an additional 2,928,382 shares in the last quarter. Ghisallo Capital Management LLC grew its stake in shares of Zevia PBC by 265.1% in the 3rd quarter. Ghisallo Capital Management LLC now owns 1,100,000 shares of the company's stock worth $2,992,000 after buying an additional 798,700 shares in the last quarter. Engineers Gate Manager LP purchased a new position in shares of Zevia PBC in the 4th quarter worth $28,000. Jefferies Financial Group Inc. purchased a new position in shares of Zevia PBC in the 4th quarter worth $4,864,000. Finally, R Squared Ltd grew its stake in shares of Zevia PBC by 228.8% in the 4th quarter. R Squared Ltd now owns 44,012 shares of the company's stock worth $102,000 after buying an additional 30,627 shares in the last quarter. 53.21% of the stock is owned by hedge funds and other institutional investors.

Zevia PBC Stock Performance

ZVIA opened at $1.29 on Monday. The stock has a market capitalization of $96.50 million, a price-to-earnings ratio of -8.57 and a beta of 0.93. The company has a fifty day moving average of $1.31 and a 200 day moving average of $1.93. Zevia PBC has a fifty-two week low of $1.11 and a fifty-two week high of $3.66.

Zevia PBC (NYSE:ZVIA - Get Free Report) last posted its earnings results on Wednesday, February 25th. The company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.01. The company had revenue of $37.87 million during the quarter, compared to analysts' expectations of $39.96 million. Zevia PBC had a negative net margin of 6.15% and a negative return on equity of 22.49%. On average, equities research analysts forecast that Zevia PBC will post -0.06 earnings per share for the current year.

Zevia PBC Company Profile

Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia's mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.

The company's product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.